Page last updated: 2024-08-23

razoxane and rutin

razoxane has been researched along with rutin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bast, A; Beems, DB; de Jong, J; Madhuizen, HT; van Acker, SA; van der Vijgh, WJ; Voest, EE	1
Bast, A; Boven, E; Grimbergen, JA; Kramer, K; Kuiper, K; van Acker, SA; van den Berg, DJ; van der Vijgh, WJ	1

Other Studies

2 other study(ies) available for razoxane and rutin

Article	Year
Cardioprotective properties of O-(beta-hydroxyethyl)-rutosides in doxorubicin-pretreated BALB/c mice. Cancer research, 1993, Oct-01, Volume: 53, Issue:19 Topics: Animals; Body Weight; Colforsin; Doxorubicin; Drug Administration Schedule; Free Radical Scavengers; Heart; Heart Rate; Hydroxyethylrutoside; Injections, Intraperitoneal; Injections, Intravenous; Isoproterenol; Male; Mice; Mice, Inbred BALB C; Myocardial Contraction; Myocardium; Razoxane; Time Factors	1993
Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin. Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:10 Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Breast Neoplasms; Cardiomyopathies; Catechin; Chelation Therapy; Cystadenocarcinoma, Serous; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Electrocardiography; Female; Flavonoids; Flavonols; Free Radical Scavengers; Free Radicals; Humans; Hydroxyethylrutoside; Iron; Iron Chelating Agents; Kaempferols; Mice; Mice, Nude; Molecular Structure; Neoplasm Transplantation; Ovarian Neoplasms; Quercetin; Razoxane; Rutin; Telemetry; Tumor Cells, Cultured; Weight Loss	1997

Article

Year

Cardioprotective properties of O-(beta-hydroxyethyl)-rutosides in doxorubicin-pretreated BALB/c mice.

Cancer research, 1993, Oct-01, Volume: 53, Issue:19

Topics: Animals; Body Weight; Colforsin; Doxorubicin; Drug Administration Schedule; Free Radical Scavengers; Heart; Heart Rate; Hydroxyethylrutoside; Injections, Intraperitoneal; Injections, Intravenous; Isoproterenol; Male; Mice; Mice, Inbred BALB C; Myocardial Contraction; Myocardium; Razoxane; Time Factors

1993

Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.

Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:10

Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Breast Neoplasms; Cardiomyopathies; Catechin; Chelation Therapy; Cystadenocarcinoma, Serous; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Electrocardiography; Female; Flavonoids; Flavonols; Free Radical Scavengers; Free Radicals; Humans; Hydroxyethylrutoside; Iron; Iron Chelating Agents; Kaempferols; Mice; Mice, Nude; Molecular Structure; Neoplasm Transplantation; Ovarian Neoplasms; Quercetin; Razoxane; Rutin; Telemetry; Tumor Cells, Cultured; Weight Loss

1997